EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Multilocus inherited neoplasia alleles syndrome in a patient with luminal B breast cancer: a case report and literature review

Katherine Aguirre-Guataqui, Natalia Hernández-Bocanegra, Paula Rueda-Gaitán, Taryn A. Castro-Cuesta, Jorge Luis Rodríguez-Sarmiento, Julian Lamilla, Mario Isaza-Ruget, Juan Javier Lopez Rivera

Frontiers in Oncology · 13.11.2026 · 16

DOI: 10.3389/fonc.2026.1913265 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 13.11.2026. Verfasst von Katherine Aguirre-Guataqui und 7 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRCA1 and BRCA2 germline deleterious variants are associated with a high risk of hereditary breast and ovarian cancer. The presence of pathogenic variants in both genes in the same individual (double heterozygosity) is rare and often associated with distinct clinical characteristics. We report a rare case of double heterozygosity involving a novel combination of pathogenic variants. A 40-year-old woman was diagnosed with stage IIIA invasive ductal carcinoma of the right breast. Histopathology revealed a grade 2, ER-positive (100%), PR-positive (70%), HER2-negative (FISH), high-proliferation Luminal B tumor. She received neoadjuvant dose-dense AC chemotherapy. Germline testing via next-generation sequencing identified two pathogenic variants: NM_007294.4 (BRCA1) :c.2105del (p.Lys701_Leu702ins*) in exon 11 and NM_000059.4 (BRCA2): c.1763_1766del (p.Asn588Serfs*25) in exon 10, both heterozygous. The patient reported a strong maternal family history of breast cancer. A systematic review of the literature and databases (PubMed, ClinVar, BRCA Exchange) did not reveal any previous clinical reports of this specific variant combination. Cases of double heterozygosity remain rare (<0.5% of BRCA carriers), and clinical data on variant-specific co-occurrence is limited. This case represents the first known report of a patient carrying both NM_007294.4 ( BRCA1 ): c.2105del (p.Lys701_Leu702ins*) and NM_000059.4 ( BRCA2 ): c.1763_1766del (p.Asn588Serfs*25) pathogenic variants. The findings contribute valuable information to the spectrum of hereditary breast cancer and underscore the importance of comprehensive genetic testing, especially in patients with strong family histories.

Zitieren

APA

Aguirre-Guataqui, K., Hernández-Bocanegra, N., Rueda-Gaitán, P., Castro-Cuesta, T. A., Rodríguez-Sarmiento, J. L., Lamilla, J., Isaza-Ruget, M., & Rivera, J. J. L. (2026). Multilocus inherited neoplasia alleles syndrome in a patient with luminal B breast cancer: a case report and literature review. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1913265

Vancouver

Aguirre-Guataqui K, Hernández-Bocanegra N, Rueda-Gaitán P, Castro-Cuesta TA, Rodríguez-Sarmiento JL, Lamilla J, et al. Multilocus inherited neoplasia alleles syndrome in a patient with luminal B breast cancer: a case report and literature review. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1913265

BibTeX
@article{AguirreGuataqui2026,
  author = {Aguirre-Guataqui, Katherine and Hernández-Bocanegra, Natalia and Rueda-Gaitán, Paula and Castro-Cuesta, Taryn A. and Rodríguez-Sarmiento, Jorge Luis and Lamilla, Julian and Isaza-Ruget, Mario and Rivera, Juan Javier Lopez},
  title = {Multilocus inherited neoplasia alleles syndrome in a patient with luminal B breast cancer: a case report and literature review},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1913265}
}
Kostenlos starten →